Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pulmonary Hypertension

Free Subscription 03.06.2024 1 Am J Perinatol 1 Am J Physiol Heart Circ Physiol 1 Am J Physiol Lung Cell Mol Physiol 2 Am J Respir Crit Care Med 1 Ann Am Thorac Soc 1 Arterioscler Thromb Vasc Biol 1 Arthritis Res Ther 1 Biochem Biophys Res Commun 1 Br J Pharmacol 1 Cardiovasc Hematol Agents Med Chem 1 Cardiovasc Pathol 1 Cardiovasc Res 1 Children (Basel) 2 Circulation 1 Clin Chest Med 1 Clin Exp Rheumatol 1 Echocardiography 1 Emergencias 2 Eur Heart J 1 Eur Heart J Open 2 Eur J Heart Fail 2 Eur Respir J 1 Heliyon 1 Inn Med (Heidelb) 2 Int J Cardiovasc Imaging 1 Int J Chron Obstruct Pulmon Dis 1 Int J Mol Sci 1 Ir Med J 1 J Am Heart Assoc 1 J Bras Pneumol 1 J Cardiovasc Med (Hagerstown) 2 J Clin Med 1 J Pediatr 1 J Pers Med 1 J Transl Med 1 J Vet Emerg Crit Care (San Antonio) 1 Medicina (Kaunas) 1 Narra J 1 Pediatr Neonatol 1 Pediatr Pulmonol 1 PLoS One 1 Pol Arch Intern Med 1 Pulm Circ 1 Respir Care 2 Respir Res 1 Rev Esp Cardiol (Engl Ed) 1 Rev Med Chil 1 Sci Rep

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Perinatol

1. GOWDA SH, Patel N
   "Heart of the Matter": Cardiac Dysfunction in Congenital Diaphragmatic Hernia.
   Am J Perinatol. 2023 Apr 3. doi: 10.1055/a-2067-7925.
   PubMed         Abstract available
   
   

   
   Am J Physiol Heart Circ Physiol

2. FUKUMITSU M, Kawada T, Nishikawa T, Yokota S, et al
   Effects of nitric oxide inhalation on pulmonary arterial impedance: Differences between normal and pulmonary hypertension male rats.
   Am J Physiol Heart Circ Physiol. 2024 May 31. doi: 10.1152/ajpheart.00108.2024.
   PubMed         Abstract available
   
   

   
   Am J Physiol Lung Cell Mol Physiol

3. SUN XQ, Klouda T, Barnasconi S, Schalij I, et al
   Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.
   Am J Physiol Lung Cell Mol Physiol. 2024 May 29. doi: 10.1152/ajplung.00105.2024
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

4. SCOTT JV, Moutchia J, McClelland RL, Al-Naamani N, et al
   Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension.
   Am J Respir Crit Care Med. 2024 May 31. doi: 10.1164/rccm.202311-2196.
   PubMed         Abstract available
   
   
5. LEMAY SE, Grobs Y, Romanet C, Martineau S, et al
   Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
   Am J Respir Crit Care Med. 2024;209:1376-1391.
   PubMed         Abstract available
   
   

   
   Ann Am Thorac Soc

6. MINHAS J, Moutchia J, Al-Naamani N, Mazurek JA, et al
   Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension.
   Ann Am Thorac Soc. 2024;21:858-865.
   PubMed         Abstract available
   
   

   
   Arterioscler Thromb Vasc Biol

7. JHENG JR, DesJardin JT, Chen YY, Huot JR, et al
   Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
   Arterioscler Thromb Vasc Biol. 2024 May 30. doi: 10.1161/ATVBAHA.123.320270.
   PubMed         Abstract available
   
   

   
   Arthritis Res Ther

8. LI Y, Qian J, Dong X, Zhao J, et al
   The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines.
   Arthritis Res Ther. 2024;26:109.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

9. CHEN Z, Cui J, Chen Z, Wang J, et al
   Pulmo-protection of long-term swimming exercise via improving insulin sensitivity in monocrotaline-induced pulmonary hypertensive rats.
   Biochem Biophys Res Commun. 2024;723:150159.
   PubMed         Abstract available
   
   

   
   Br J Pharmacol

10. CSAKI R, Nagaraj C, Almassy J, Khozeimeh MA, et al
    The TREK-1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension.
    Br J Pharmacol. 2024 May 28. doi: 10.1111/bph.16426.
    PubMed         Abstract available
    
    

    
    Cardiovasc Hematol Agents Med Chem

11. ALJANABI MA, Alrabadi N, Mahmoud SH, Haddad R, et al
    Sildenafil Effect on Atrial Natriuretic Peptide Level in Pulmonary Hypertensive Rats.
    Cardiovasc Hematol Agents Med Chem. 2024.
    PubMed         Abstract available
    
    

    
    Cardiovasc Pathol

12. GUTOR SS, Richmond BW, Agrawal V, Brittain EL, et al
    Pulmonary vascular disease in Veterans with post-deployment respiratory syndrome.
    Cardiovasc Pathol. 2024;71:107640.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

13. LIU B, Azfar M, Legchenko E, West JA, et al
    ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.
    Cardiovasc Res. 2024;120:756-768.
    PubMed         Abstract available
    
    

    
    Children (Basel)

14. SCHROEDER L, Soltesz L, Leyens J, Strizek B, et al
    Vasoactive Management of Pulmonary Hypertension and Ventricular Dysfunction in Neonates Following Complicated Monochorionic Twin Pregnancies: A Single-Center Experience.
    Children (Basel). 2024;11:548.
    PubMed         Abstract available
    
    

    
    Circulation

15. JHENG JR, Bai Y, Noda K, Huot JR, et al
    Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624.
    PubMed         Abstract available
    
    
16. SALAHUDDIN A, Harris IS, Sabanayagam A
    Double Whammy Complicating Management of Pulmonary Hypertension.
    Circulation. 2024;149:1770-1774.
    PubMed        
    
    

    
    Clin Chest Med

17. MOORE J, Altschul E, Remy-Jardin M, Raoof S, et al
    Chronic Thromboembolic Pulmonary Hypertension: Clinical and Imaging Evaluation.
    Clin Chest Med. 2024;45:405-418.
    PubMed         Abstract available
    
    

    
    Clin Exp Rheumatol

18. BEARZI P, Navarini L, Currado D, Marino A, et al
    Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis.
    Clin Exp Rheumatol. 2024 May 28. doi: 10.55563.
    PubMed         Abstract available
    
    

    
    Echocardiography

19. YANG L, Luo D, Huang T, Li X, et al
    New risk model by right ventricle - pulmonary arterial coupling and inferior vena cava from echocardiography in patients with conventional low-intermediate risk pulmonary artery hypertension under targeted treatment.
    Echocardiography. 2024;41:e15850.
    PubMed         Abstract available
    
    

    
    Emergencias

20. TORRES ARRESE M, Barbera Rausell P, Lago Gancedo H, Mata Martinez A, et al
    Usefulness of the pulsed wave doppler flow pattern in the common femoral vein to detect high probability of pulmonary hypertension in patients attended in the emergency department.
    Emergencias. 2024;36:234.
    PubMed        
    
    

    
    Eur Heart J

21. MOUTCHIA J, McClelland RL, Al-Naamani N, Appleby DH, et al
    Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.
    Eur Heart J. 2024 Feb 28:ehae049. doi: 10.1093.
    PubMed         Abstract available
    
    
22. PITRE T, Weatherald J, Humbert M
    Treatments for pulmonary arterial hypertension: navigating through a network of choices.
    Eur Heart J. 2024 Mar 5:ehae106. doi: 10.1093.
    PubMed        
    
    

    
    Eur Heart J Open

23. MAEDER MT, Weber L, Pohle S, Chronis J, et al
    Impact of the 2022 pulmonary hypertension definition on haemodynamic classification and mortality in patients with aortic stenosis undergoing valve replacement.
    Eur Heart J Open. 2024;4:oeae037.
    PubMed         Abstract available
    
    

    
    Eur J Heart Fail

24. PLATZ E, Systrom D, Leopold JA
    Pulmonary congestion in patients with pulmonary arterial hypertension? New insights from lung ultrasound.
    Eur J Heart Fail. 2024;26:825-828.
    PubMed        
    
    
25. D'ALTO M, Di Maio M, Argiento P, Romeo E, et al
    Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension.
    Eur J Heart Fail. 2024 Feb 26. doi: 10.1002/ejhf.3172.
    PubMed         Abstract available
    
    

    
    Eur Respir J

26. NATHAN SD, Argula R, Trivieri MG, Aziz S, et al
    Inhaled Treprostinil in Pulmonary Hypertension Associated with COPD: PERFECT study results.
    Eur Respir J. 2024 May 29:2400172. doi: 10.1183/13993003.00172-2024.
    PubMed         Abstract available
    
    
27. VALDEOLMILLOS E, Foray C, Albenque G, Batteux C, et al
    Percutaneous atrial septal defect closure in patients with pulmonary arterial hypertension.
    Eur Respir J. 2024;63:2301649.
    PubMed        
    
    

    
    Heliyon

28. KOIKE H, Nishimura T, Morikawa M
    Quantitative evaluation of pulmonary hypertension using 4D flow MRI: A retrospective study.
    Heliyon. 2024;10:e31177.
    PubMed         Abstract available
    
    

    
    Inn Med (Heidelb)

29. EICHSTAEDT CA, Shaukat M, Grunig E
    [Heritable pulmonary arterial hypertension].
    Inn Med (Heidelb). 2024;65:560-565.
    PubMed         Abstract available
    
    

    
    Int J Cardiovasc Imaging

30. LIN K, Sarnari R, Gordon DZ, Markl M, et al
    Radiomics features of the cardiac blood pool to indicate hemodynamic changes in pulmonary hypertension (PH) due to heart failure with preserved ejection fraction (PH-HFpEF).
    Int J Cardiovasc Imaging. 2024 May 27. doi: 10.1007/s10554-024-03131.
    PubMed         Abstract available
    
    
31. NISHII T, Horinouchi H, Namboku T, Sofue K, et al
    Laterality of CT-measured hepatic extracellular volume fraction in patients with chronic thromboembolic pulmonary hypertension.
    Int J Cardiovasc Imaging. 2024 May 26. doi: 10.1007/s10554-024-03119.
    PubMed         Abstract available
    
    

    
    Int J Chron Obstruct Pulmon Dis

32. BAJWA EK, Cislak D, Kumar A, Li D, et al
    Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
    Int J Chron Obstruct Pulmon Dis. 2024;19:1105-1121.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

33. AWAD KS, Wang S, Dougherty EJ, Keshavarz A, et al
    BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARgamma Signaling in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2024;25:5403.
    PubMed         Abstract available
    
    

    
    Ir Med J

34. HIGGINS M, Cullivan S, McCullagh B, Gaine S, et al
    Characteristics of sarcoidosis-associated pulmonary hypertension at the National Pulmonary Hypertension Unit.
    Ir Med J. 2024;117:955.
    PubMed        
    
    

    
    J Am Heart Assoc

35. AGRAWAL A, Bajaj S, Bhagat U, Yesilyaprak A, et al
    Cardiovascular Complications With Delivery Hospitalizations in Patients With Pulmonary Hypertension: A Nationwide Study From 2011 to 2020.
    J Am Heart Assoc. 2024 May 28:e031632. doi: 10.1161/JAHA.123.031632.
    PubMed         Abstract available
    
    

    
    J Bras Pneumol

36. FERREIRA EVM, Lucena JS, Oliveira RKF
    The role of the pulmonary function laboratory to assist in disease management: pulmonary hypertension.
    J Bras Pneumol. 2024;50:e20240033.
    PubMed        
    
    

    
    J Cardiovasc Med (Hagerstown)

37. PALAZZUOLI A, Dini FL, Agostoni P, Cartocci A, et al
    Right ventricular dysfunction in chronic heart failure: clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry).
    J Cardiovasc Med (Hagerstown). 2024;25:457-465.
    PubMed         Abstract available
    
    

    
    J Clin Med

38. BERTICI RA, Bertici NS, Ridichie A, Fira-Mladinescu O, et al
    Comorbidities, Treatment and Survival Rates of Chronic Thromboembolic Pulmonary Hypertension in a Regional Centre.
    J Clin Med. 2024;13:2754.
    PubMed         Abstract available
    
    
39. BALCAN B, Akdeniz B, Peker Y, The Turcosact Collaborators, et al
    Obstructive Sleep Apnea and Pulmonary Hypertension: A Chicken-and-Egg Relationship.
    J Clin Med. 2024;13:2961.
    PubMed         Abstract available
    
    

    
    J Pediatr

40. HERNANDEZ BS, Shinozaki RM, Grady RM, Drussa A, et al
    Improvement in Echocardiographic and Diagnostic Biomarkers after Systemic Glucocorticoid Therapy in Infants with Pulmonary Hypertension.
    J Pediatr. 2024 May 28:114116. doi: 10.1016/j.jpeds.2024.114116.
    PubMed         Abstract available
    
    

    
    J Pers Med

41. KADOGLOU NPE, Khattab E, Velidakis N, Gkougkoudi E, et al
    The Role of Echocardiography in the Diagnosis and Prognosis of Pulmonary Hypertension.
    J Pers Med. 2024;14:474.
    PubMed         Abstract available
    
    

    
    J Transl Med

42. LI X, Ma S, Wang Q, Li Y, et al
    A new integrative analysis of histopathology and single cell RNA-seq reveals the CCL5 mediated T and NK cell interaction with vascular cells in idiopathic pulmonary arterial hypertension.
    J Transl Med. 2024;22:502.
    PubMed         Abstract available
    
    

    
    J Vet Emerg Crit Care (San Antonio)

43. GELE RR, Burnotte P, Valcke A, Walker TG, et al
    Retrospective evaluation of a right heart parameter score in the assessment of precapillary pulmonary hypertension in dogs (2017-2021): 135 cases.
    J Vet Emerg Crit Care (San Antonio). 2024 May 29. doi: 10.1111/vec.13394.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

44. RUDIENE V, Kapleriene L, Laukyte-Sleniene M, Zebrauskiene D, et al
    The Impact of COVID-19 Infection on Patients with Severe Chronic Pulmonary Hypertension: A Prospective Study from a Single Referral Center.
    Medicina (Kaunas). 2024;60:750.
    PubMed         Abstract available
    
    

    
    Narra J

45. SIREGAR FM, Hartopo AB, Haryana SM
    Recent progress in the roles of microRNAs in pulmonary arterial hypertension associated with congenital heart disease.
    Narra J. 2024;4:e579.
    PubMed         Abstract available
    
    

    
    Pediatr Neonatol

46. KASHAKI M, Mohazzab A, Radgoudarzi M, Bordbar A, et al
    Study on the comparison between Bosentan and Macitentan in the treatment of persistent pulmonary hypertension of the newborns, simultaneously on sildenafil: A randomized double-blinded non-inferiority parallel clinical trial.
    Pediatr Neonatol. 2024 May 22:S1875-9572(24)00077.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

47. FUKUOKA S, Kaku N, Nagata H, Nagatomo Y, et al
    Extracorporeal membrane oxygenation support for balloon atrial septostomy in a BMPR2 variant-associated pulmonary arterial hypertension.
    Pediatr Pulmonol. 2024;59:1789-1791.
    PubMed        
    
    

    
    PLoS One

48. KRONBERGER C, Willixhofer R, Mousavi RA, Grzeda MT, et al
    The one-minute sit-to-stand-test performance is associated with health-related quality of life in patients with pulmonary hypertension.
    PLoS One. 2024;19:e0301483.
    PubMed         Abstract available
    
    

    
    Pol Arch Intern Med

49. JERMAKOW M, Danielewicz K, Dudzinska K, Bienias P, et al
    Transient severe precapillary pulmonary hypertension caused by eosinophilic granulomatosis with polyangiitis in a patient diagnosed with asthma.
    Pol Arch Intern Med. 2024 May 24:16758. doi: 10.20452/pamw.16758.
    PubMed        
    
    

    
    Pulm Circ

50. HERSI K, Ramani GV, Law JY, Sadek AS, et al
    Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A review.
    Pulm Circ. 2024;14:e12362.
    PubMed         Abstract available
    
    

    
    Respir Care

51. EVANS RA
    The Rationale, Evidence, and Adaptations to Pulmonary Rehabilitation for Chronic Respiratory Diseases Other Than COPD.
    Respir Care. 2024;69:697-712.
    PubMed         Abstract available
    
    

    
    Respir Res

52. YANG Q, Lai B, Xie H, Deng M, et al
    Identification of differentially expressed ER stress-related genes and their association with pulmonary arterial hypertension.
    Respir Res. 2024;25:220.
    PubMed         Abstract available
    
    
53. BA H, Guo Y, Jiang Y, Li Y, et al
    Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics.
    Respir Res. 2024;25:221.
    PubMed         Abstract available
    
    

    
    Rev Esp Cardiol (Engl Ed)

54. COUTO-MALLON D, Enriquez-Vazquez D, Calvino-Santos R, Velasco-Garcia de Sierra C, et al
    Usefulness of remote pulmonary arterial pressure monitoring in patients with advanced heart failure listed for HT.
    Rev Esp Cardiol (Engl Ed). 2024;77:493-495.
    PubMed        
    
    

    
    Rev Med Chil

55. ACUNA B, Bello-Zepeda J, Montenegro G, Reyes RV, et al
    [Pulmonary hypertension: calcium channel-mediated signaling, present and future pharmacological targets].
    Rev Med Chil. 2023;151:753-763.
    PubMed         Abstract available
    
    

    
    Sci Rep

56. LIN J, Chen R, Liao H, Zhang Y, et al
    Mechanisms of cordycepin in the treatment of pulmonary arterial hypertension in rats based on metabonomics and transcriptomics.
    Sci Rep. 2024;14:12431.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.